STAT4 genetic polymorphisms association with spontaneous clearance of hepatitis B virus infection

Immunologic Research

Volumn 62, Issue 2, 2015, Pages 146-152

  Lu, Yanjun ^a   Zhu, Yaowu ^a   Peng, Jing ^a   Wang, Xiong ^a   Wang, Feng ^a   Sun, Ziyong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Genotype; Hepatitis B virus; Single nucleotide polymorphism; STAT4

Indexed keywords

GENOMIC DNA; MESSENGER RNA; STAT4 PROTEIN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; CHRONIC HEPATITIS B; COMPLICATION; GENETIC POLYMORPHISM; GENETICS; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; ODDS RATIO; PHYSIOLOGY; VIROLOGY; VIRUS LOAD;

ADULT; ALLELES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STAT4 TRANSCRIPTION FACTOR; VIRAL LOAD;

EID: 84929702598     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8645-1     Document Type: Article

References (28)

1. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol. 1997;26(3):503–7.
2. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol. 2003;9(4):641–4.
3. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995;332(16):1065–9. doi:10.1056/NEJM199504203321604.
4. Murray JM, Wieland SF, Purcell RH, Chisari FV. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA. 2005;102(49):17780–5. doi:10.1073/pnas.0508913102.
5. Cavanaugh VJ, Guidotti LG, Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol. 1998;72(4):2630–7.
6. Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, et al. Critical role for STAT4 activation by type 1 interferons in the interferon–gamma response to viral infection. Science. 2002;297(5589):2063–6. doi:10.1126/science.1074900.
7. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O’Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev. 2004;202:139–56. doi:10.1111/j.0105-2896.2004.00211.x.
8. Allen SJ, Mott KR, Ghiasi H. Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice. Mol Vis. 2010;16:98–104.
9. Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4 + T cells in herpetic stromal keratitis pathogenesis. J Interferon Cytokine Res. 2007;27(1):65–75. doi:10.1089/jir.2007.0077.
10. Bot A, Rodrigo E, Wolfe T, Bot S, Von Herrath MG. Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens. J Virol. 2003;77(10):5794–800.
11. Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J Immunol. 1999;163(10):5374–82.
12. Deng JC, Zeng X, Newstead M, Moore TA, Tsai WC, Thannickal VJ, et al. STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection. J Immunol. 2004;173(6):4075–83.
13. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357(10):977–86. doi:10.1056/NEJMoa073003.
14. Park Y, Lee HS, Park Y, Min D, Yang S, Kim D, et al. Evidence for the role of STAT4 as a general autoimmunity locus in the Korean population. Diabetes Metab Res Rev. 2011;27(8):867–71. doi:10.1002/dmrr.1263.
15. Glas J, Seiderer J, Nagy M, Fries C, Beigel F, Weidinger M, et al. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn’s disease and early disease onset. PLoS ONE. 2010;5(4):e10373. doi:10.1371/journal.pone.0010373.
16. Glas J, Seiderer J, Wagner J, Olszak T, Fries C, Tillack C, et al. Analysis of IL12B gene variants in inflammatory bowel disease. PLoS ONE. 2012;7(3):e34349. doi:10.1371/journal.pone.0034349.
17. Svensson A, Tunback P, Nordstrom I, Shestakov A, Padyukov L, Eriksson K. STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection. J Virol. 2012;86(17):9409–15. doi:10.1128/JVI.00947-12.
18. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet. 2013;45(1):72–5. doi:10.1038/ng.2483.
19. Kim SW, Kim ES, Moon CM, Kim TI, Kim WH, Cheon JH. Abnormal genetic and epigenetic changes in signal transducer and activator of transcription 4 in the pathogenesis of inflammatory bowel diseases. Dig Dis Sci. 2012;57(10):2600–7. doi:10.1007/s10620-012-2199-z.
20. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, et al. Identification of a susceptibility locus in STAT4 for Behcet’s disease in Han Chinese in a genome-wide association study. Arthritis Rheum. 2012;64(12):4104–13. doi:10.1002/art.37708.
21. Zhao Y, Liu X, Liu X, Su Y, Li Y, Zhang X, et al. Association of STAT4 gene polymorphism with increased susceptibility of rheumatoid arthritis in a northern Chinese Han subpopulation. Int J Rheum Dis. 2013;16(2):178–84. doi:10.1111/1756-185X.12093.
22. Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A. An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods. 1991;34(1):105–12.
23. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z et al. A partition–ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009;19(4):519–23. doi:10.1038/cr.2009.33.
24. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med. 1995;181(3):1047–58.
25. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996;4(1):25–36.
26. Korman BD, Kastner DL, Gregersen PK, Remmers EF. STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep. 2008;8(5):398–403.
27. Abelson AK, Delgado-Vega AM, Kozyrev SV, Sanchez E, Velazquez-Cruz R, Eriksson N, et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis. 2009;68(11):1746–53. doi:10.1136/ard.2008.097642.
28. Schurich A, Pallett LJ, Lubowiecki M, Singh HD, Gill US, Kennedy PT, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 2013;9(3):e1003208. doi:10.1371/journal.ppat.1003208.